NPI: 1376656959 · NEW LONDON, WI 54961 · Family Medicine Physician · NPI assigned 08/16/2006
Authorized official FLETT, WILLIAM controls 20+ related entities in our dataset. Read more
| Authorized Official | FLETT, WILLIAM (CFO) |
| NPI Enumeration Date | 08/16/2006 |
Other providers sharing the same authorized official: FLETT, WILLIAM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 66,946 | $1.80M |
| 2019 | 68,186 | $1.85M |
| 2020 | 48,519 | $1.38M |
| 2021 | 70,215 | $2.07M |
| 2022 | 78,296 | $2.37M |
| 2023 | 84,656 | $2.46M |
| 2024 | 64,100 | $2.98M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 157,794 | 142,991 | $6.32M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 186,510 | 169,956 | $5.50M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8,162 | 7,422 | $369K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 13,034 | 12,225 | $268K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4,099 | 3,845 | $236K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3,737 | 3,623 | $217K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 7,934 | 4,706 | $175K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2,585 | 2,385 | $160K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5,255 | 4,804 | $154K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 4,368 | 4,108 | $134K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2,061 | 1,995 | $118K |
| 90686 | 15,484 | 14,938 | $118K | |
| 99215 | Prolong outpt/office vis | 1,915 | 1,633 | $86K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 14,653 | 12,640 | $83K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 105 | 85 | $78K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,392 | 1,274 | $68K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,990 | 2,732 | $58K |
| 3008F | 5,854 | 5,557 | $53K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,144 | 2,943 | $46K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 2,880 | 1,314 | $41K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 98 | 90 | $35K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 427 | 391 | $34K |
| J2315 | Injection, naltrexone, depot form, 1 mg | 29 | 26 | $29K |
| 20611 | 764 | 698 | $29K | |
| 93227 | 1,645 | 1,537 | $25K | |
| 87631 | 240 | 214 | $24K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 60 | 56 | $23K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,003 | 2,762 | $22K |
| 0002A | 552 | 539 | $20K | |
| 93000 | 1,776 | 1,657 | $18K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 304 | 289 | $17K |
| 0001A | 529 | 506 | $17K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 894 | 428 | $13K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 251 | 73 | $13K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 19 | 15 | $13K |
| 0072A | 385 | 284 | $12K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 183 | 172 | $12K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 753 | 674 | $12K |
| 93296 | 1,107 | 1,051 | $12K | |
| 0071A | 383 | 288 | $11K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 261 | 255 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,518 | 1,355 | $11K |
| 99223 | Prolong inpt eval add15 m | 228 | 219 | $11K |
| 90677 | 188 | 173 | $10K | |
| 0012A | 266 | 264 | $10K | |
| 0011A | 292 | 282 | $10K | |
| 93018 | 960 | 912 | $9K | |
| 0004A | 225 | 199 | $7K | |
| 95886 | 124 | 110 | $7K | |
| 99233 | Prolong inpt eval add15 m | 332 | 137 | $7K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 2,119 | 1,935 | $7K |
| 90670 | 1,706 | 1,667 | $7K | |
| 92551 | 474 | 446 | $6K | |
| 99239 | Hospital discharge day management, more than 30 minutes | 136 | 133 | $6K |
| 99222 | Initial hospital care, per day, moderate complexity | 182 | 171 | $6K |
| 71046 | Radiologic examination, chest; 2 views | 511 | 485 | $5K |
| 99349 | 161 | 143 | $5K | |
| 93294 | 425 | 412 | $5K | |
| 0064A | 156 | 129 | $5K | |
| 80061 | Lipid panel | 429 | 378 | $5K |
| 93016 | 300 | 285 | $4K | |
| 99205 | Prolong outpt/office vis | 60 | 55 | $4K |
| 90723 | 724 | 704 | $4K | |
| 80306 | 189 | 160 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 15 | 12 | $3K |
| 20610 | 87 | 75 | $3K | |
| 80076 | 367 | 345 | $3K | |
| 90647 | 450 | 433 | $3K | |
| 99421 | 326 | 254 | $3K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 20 | 16 | $2K |
| 0124A | 73 | 66 | $2K | |
| 95251 | 153 | 143 | $2K | |
| 93295 | 67 | 65 | $2K | |
| 90680 | 384 | 373 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 576 | 548 | $2K |
| 64644 | 56 | 51 | $2K | |
| 0031A | 47 | 43 | $2K | |
| 93272 | 81 | 74 | $2K | |
| 99336 | 58 | 52 | $2K | |
| 62323 | 14 | 14 | $1K | |
| 90685 | 425 | 414 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 218 | 199 | $1K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 63 | 51 | $1K |
| 72170 | 110 | 97 | $1K | |
| 0052A | 46 | 36 | $1K | |
| 73610 | 92 | 77 | $1K | |
| 99220 | 28 | 26 | $1K | |
| 90688 | 83 | 82 | $1K | |
| 90656 | 73 | 73 | $1K | |
| 99152 | 67 | 45 | $977.01 | |
| 73564 | 56 | 51 | $976.86 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 27 | 26 | $883.33 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 154 | 145 | $869.41 |
| 0054A | 29 | 24 | $847.52 | |
| 73630 | 57 | 50 | $830.72 | |
| 0134A | 27 | 27 | $804.78 | |
| 95874 | 99 | 93 | $735.53 | |
| 11045 | 74 | 29 | $693.28 | |
| 99219 | 12 | 12 | $670.62 | |
| 73030 | 41 | 37 | $656.33 | |
| 81001 | 193 | 184 | $587.24 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 13 | 12 | $548.80 |
| 0154A | 16 | 15 | $534.24 | |
| 99174 | 2,267 | 2,151 | $526.67 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 64 | 54 | $502.20 |
| 73110 | 16 | 12 | $420.91 | |
| 99335 | 37 | 30 | $376.95 | |
| 20552 | 17 | 12 | $316.90 | |
| 90633 | 90 | 88 | $316.48 | |
| 93308 | 14 | 12 | $301.50 | |
| 97597 | 22 | 12 | $252.59 | |
| 73552 | 19 | 12 | $232.68 | |
| 99305 | 13 | 13 | $221.34 | |
| 36415 | Collection of venous blood by venipuncture | 527 | 476 | $214.18 |
| 72100 | 16 | 15 | $210.02 | |
| 99497 | 13 | 12 | $197.56 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 13 | 12 | $193.73 |
| 73562 | 14 | 14 | $183.19 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 12 | 12 | $172.09 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 14 | 13 | $147.50 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 15 | 14 | $137.96 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 52 | 45 | $137.51 |
| 99173 | 12 | 12 | $130.80 | |
| 93321 | 14 | 12 | $86.36 | |
| 90734 | 26 | 26 | $79.74 | |
| 90651 | 26 | 25 | $79.54 | |
| 90715 | 13 | 13 | $67.99 | |
| 93325 | 29 | 25 | $59.14 | |
| 99406 | 12 | 12 | $33.37 | |
| 81003 | 13 | 13 | $22.50 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 26 | 24 | $9.45 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 13 | 13 | $4.35 |
| 91313 | 24 | 24 | $0.00 | |
| 91300 | 1,424 | 1,266 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 14 | 12 | $0.00 |
| 97803 | 27 | 27 | $0.00 | |
| 91311 | 15 | 14 | $0.00 | |
| 91312 | 71 | 64 | $0.00 | |
| 91307 | 819 | 597 | $0.00 | |
| 91301 | 613 | 589 | $0.00 | |
| 91306 | 151 | 124 | $0.00 | |
| 91305 | 116 | 92 | $0.00 | |
| 91315 | 16 | 15 | $0.00 | |
| 91303 | 108 | 63 | $0.00 |